Search

everythinglearnresearchcommunity

for

Search:↓

Derma Genie™-H001 can help prevent hair loss and promote hair growth.

Dihydrotestosterone might cause migraines, and finasteride could help reduce them.

Vitamin D receptor helps control skin cell growth and hair development.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

The vitamin D receptor helps regulate skin and hair health independently of its usual vitamin D ligand.

Lower DHT levels lead to more body hair growth.

A mutation in the vitamin D receptor causes severe resistance to vitamin D, affecting bone health but not hair growth.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Mice without Vitamin D receptors have hair growth problems because of issues in the hedgehog signaling pathway.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

PCE-DP brightens skin and promotes hair growth by enhancing cell growth and reducing melanin uptake.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

Mutations in the hairless protein gene cause hair loss.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

t-Flavanone may help hair growth by reducing a specific protein's activity in skin cells.

Researchers found key regions in the mouse hairless gene that control its activity in skin and brain cells, affecting hair follicle function.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Vitamin D3 affects cell differentiation in specific skin areas.

Testosterone in human pancreas cells boosts insulin production.

Testosterone and dihydrotestosterone can slow down the growth of certain hair follicle cells.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The study created a new method to test drugs that affect hormone processing in skin.

TGase 3 helps build hair structure by forming strong bonds between proteins.

Liposomes are not better than acetone for applying DHT on skin.

Dkk4 is necessary for the initial development and arrangement of hair follicles.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

DHCer levels in hair could be a biomarker for alopecia progression.